MedPath
NMPA Approval

Everolimus Tablets

国药准字H20253001

January 2, 2025

Drug Information

依维莫司片

片剂

5mg

化学药品

January 2, 2025

Company Information

Applicant Company

中国(江苏)自由贸易试验区苏州片区苏州工业园区星湖街218号生物医药产业园一期B2楼707D单元

Manufacturing Company

苏州工业园区星湖街218号C25楼、C26楼、C28楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依维莫司片 - NMPA 批准文号 | MedPath